One big disadvantage is that they don't provide much fiber
The CEO of Swiss pharmaceutical giant Galderma told Bloomberg in 2024 that he sees a strong demand for facial fillers to counteract the sunken look that some GLP-1 users develop
Patients benefit from continuing their existing acid-suppression therapy while beginning GLP-1 treatment
Figure 1 provides multiple pharmacotherapy options based on A1C levels, fasting or postprandial glucose control, weight loss, and adverse effects
reported no significant effects on BMC, BMD or bone turnover markers (such as osteocalcin, CTX, IGF-1)
Bacteriophages, as integral constituents of the gut virome, play pivotal roles in modulating bacterial community dynamics and show potential as precision antimicrobial or gene-delivery vectors